GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-based biotech violated multiple patents with its duo of approved mRNA vaccines.